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in 2005-2010. The etiology and type of valvular heart disease have been clas-
sified on the basis of surgicalreports.
Results: The distribution of etiologies differed significantly different
between the two periods (p<0.0001). We noted a decrease in rheumatic
valvular disease with 1,558 cases (95%) in the first period and 894 cases
(81%) in the second period. Consistantly, we observed an increase in
degenerative etiology from 1.6% to 16%, and particularly fibroelastic
degeneration: 20 (1.6%) and 146 (13.3%) cases. The mechanism of val-
vular disease (mitral regurgitation versus mixed mitral valve disease and
mitral stenosis) differed significantly (p<0.0001) for both periods. With
regard to mitral regurgitation cases only, degenerative etiologies increased
from 11.4% to 38.5% of cases between the two periods (p<0.0001).
Patients had a mean age of 36.3 years with a female predominance (two
thirds of patients), especially in rheumatic etiologies. Age (p<0.0001) and
the proportion of urban residents (p=0.04) was increased in degenerative
causes.
Conclusion: The study shows the emergence of degenerative valvular
disease in Vietnam and a decrease in rheumatic valvular heart disease, which
nevertheless remains the most common etiology. 
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The mitral valve prolapse (MVP) is a common cardiac disorder which
affects 2-4% of the population and remains one of the most frequent
indications for valvular surgery. The familial nature of MVP has been
proposed for many years and so far, FLNA remains the only identified
gene. 
Recently, it has been shown that FLNA mutations deregulate the RhoA/
Rac1 GTPases balance and provided evidences for a role of the Rac1 specific
GTPase activating protein, FilGAP, in this network. FilGAP is a recognized
FlnA-binding RhoGTPase-activating protein.
Giving the tight interactions of FlnA and FilGAP, we first tested, using a
candidate gene approach, the hypothesis that FilGAP, encoded by ARHGAP24,
could be involved in MVP.
We have sequenced ARHGAP24 in 95 MVP operated patients and identi-
fied 3 rare missense mutations in highly conserve residues (FilGAP p.R95Q;
p.P417H and p.T481M). One mutation was novel and the 2 others present a
minor allele frequency lower than 0.1% in EVS. Moreover, p.T481M co-seg-
regates with the pathology in a family with 3 affected patients.
We then investigated the impact of these mutations in HEK293 cells. The
role of FilGAP is to decrease Rac1 activity and thus to regulate cell processes
involved in actin cytoskeleton properties as adhesion, protrusion and intracel-
lular dynamics.
From pull-down assays, we have shown that FilGAP mutations alter Rac1
GTPase activity and significantly decrease the FilGAP interaction with the
active form of Rac1 (p<0.01). We have also shown, using the XCELLigence
system, that cell adhesion and spreading was significantly increased with
mutated FilGAP (p<0.01). Our results indicate that ARHGAP24 variants are
loss-function mutations.
Moreover, we demonstrate that FilGAP mutations alter the downstream
signaling pathway by two different mechanisms. FilGAP p.P417H and
p.T481M decrease the interaction with FlnA while p.R95Q impacts the plasma
membrane anchorage. 
This work reinforces the involvement of GTPases pathway in MVP patho-
genesis.
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Background: In stress echo Doppler cardiac of mitral stenosis (MS), the
cut point of the mean mitral gradient (MMG) at the peak of the effort pro-
posed by the American Recommendations for mitral dilation is 15mmHg.
However, this value is questioned in the literature
Objective: In stress echo Doppler, determine the peak effort cutoff value
of the MMG prediction of the occurrence of dyspnea justifying percutaneous
mitral dilation in patients with MS
Methodology: Prospective descriptive study conducted in the Cardiology
Department Hospital Beni Messous (Algiers) between March 2008 and
December 2010. Have been included patients with mitral area ≤2 cm², func-
tional class I to III NYHA and systolic pulmonary artery pressure ≤60mm Hg
at rest. Dyspnea was sought to stress test on a treadmill (30W/3min). Dyspneic
patients are those who have stopped the examination for a load ≤90W due to
the occurrence of severe dyspnea. The stress echo Doppler was performed on
table echocardiography (30W/3min). The MMG was measured at baseline and
at the end of each level to the peak of the effort 
Results: Three hundred patients were included (mean age 42.3±1.3 years,
81.3% female). At the end of the stress test, 182 had dyspnea (60.6%). Areas
under the curve of the MMG at peak stress is equal to 0.80, 95% confidence
interval= 0.75-0.85 (p<10-3). In predicting dyspnea justifying percutaneous
mitral dilation, the optimal cutoff value of the MMG corresponds to 33.5
mmHg: sensitivity=0.55, specificity=0.96, positive likelihood=13.21, positive
predictive value (PPV) =95%, positive predictive error (PPE) =5%, Informa-
tive Expected Capacity (IEC) =109. However, the diagnostic quality of the
MMG at maximum effort with the cut point of 15 mmHg proposed by the
American Recommendations is low: sensitivity=0.98, specificity=0.008, posi-
tive likelihood=0.98, PPV=60.0%, PPE=40.0%, IEC= 0.25.
Conclusion: In this study, the optimal cutoff value of the MMG predictive
peak effort dyspnea justifying the percutaneous mitral dilation is 33.5 mmHg,
above the cut point proposed by American Guidelines. 
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Assessment of paravalvular aortic regurgitation (AR) after transcatheter
aortic valve implantation (TAVI) using Edwards SAPIEN XT valve remains
challenging using transthoracic echocardiography (TTE) or angiography. Car-
diac magnetic resonance imaging (c-MRI) has a low intraobserver and
interobserver variability in the assessment of regurgitant volumes and might
be more reliable to assess AR post-TAVI. We therefore aimed to evaluate the
value of c-MRI to assess paravalvular AR after TAVI. Between February
2012 and March 2013, 132 consecutive patients underwent successful TAVI
using exclusively Edwards SAPIEN XT prosthesis. AR was evaluated by c-
MRI, TTE and angiography in 45 patients (27 women, mean age 84.1±7.1
years). Angiography was performed immediately after TAVI whereas TTE
and c-MRI were performed one month after implantation. At baseline c-MRI,
the mean aortic regurgitant fraction (ARF) was 21.3±12.5%. A significant AR
(> grade II) was present in 24 (56%) patients using c-MRI (30< ARF>50 Y%)
whereas it was only observed in 18 (40%) and 12 (27%) patients using TTE
and angiography, respectively. Interestingly, there was a poor correlation
between c-MRI and TTE (r=0.16, p=0.28) and between c-MRI and angio-
graphy (r=0.30, p=0.06). In contrast, there was a good correlation between
TTE and angiography (r=0.6, p<0.001). TTE underestimated AR by one
degree in 9 patients, and by two degrees in 6 patients as compared to c-MRI.
The results of our study suggest that TTE and angiography may underestimate
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